• 1. Evolved polymerases facilitate selection of fully 2′-OMe-modified aptamers?
  Zhixia Liu,Tingjian Chen,Floyd E. Romesberg Chem. Sci., 2017,8, 8179-8182
• 2. Evolving better nanoparticles: Genetic algorithms for optimising cluster geometries
  Dalton Trans., 2003, 4193-4207
• 3. Embedding heteroatoms: an effective approach to create porphyrin-based functional materials
  Norihito Fukui,Keisuke Fujimoto,Hideki Yorimitsu,Atsuhiro Osuka Dalton Trans., 2017,46, 13322-13341
• 4. Evolution of hierarchical porous structures in supramolecular guest–host hydrogels?
  Christopher B. Rodell,Christopher B. Highley,Minna H. Chen,Neville N. Dusaj,Chao Wang,Lin Han,Jason A. Burdick Soft Matter, 2016,12, 7839-7847
• 5. Exchanged ligands on the surface of a giant cluster: [(MoO3)176(H2O)63(CH3OH)17Hn](32 – n)–
  Chem. Commun., 1998, 1501-1502

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Benzothiazoles Benzothiazoles
• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Benzothiazoles

Introduction to N-(2-methylpropyl)-1,3-benzothiazol-2-amine (CAS No: 24622-32-0)

N-(2-methylpropyl)-1,3-benzothiazol-2-amine, a compound with the chemical formula C₁₁H₁₅N₂S, is a significant molecule in the field of pharmaceutical and chemical research. This compound is identified by its unique CAS number, CAS No: 24622-32-0, which serves as a distinct identifier in scientific literature and databases. The molecular structure of N-(2-methylpropyl)-1,3-benzothiazol-2-amine features a benzothiazole core, which is a well-known scaffold in medicinal chemistry due to its diverse biological activities.

The benzothiazole moiety is particularly interesting because it exhibits a wide range of pharmacological properties, including antimicrobial, anti-inflammatory, and anticancer effects. The presence of the amine functional group at the 2-position and the isobutyl group at the nitrogen atom enhances the compound's potential for further derivatization and biological evaluation. This structural feature makes N-(2-methylpropyl)-1,3-benzothiazol-2-amine a valuable intermediate in the synthesis of more complex molecules designed for therapeutic applications.

In recent years, there has been growing interest in benzothiazole derivatives as they have shown promise in various preclinical studies. Researchers have been exploring ways to optimize the pharmacokinetic and pharmacodynamic properties of these compounds. The N-(2-methylpropyl)-1,3-benzothiazol-2-amine molecule has been studied for its potential role in inhibiting specific enzymes and receptors that are involved in disease pathways. For instance, studies have suggested that modifications to the benzothiazole core can lead to enhanced binding affinity and selectivity for target proteins.

The synthesis of N-(2-methylpropyl)-1,3-benzothiazol-2-amine involves multi-step organic reactions that require careful optimization to ensure high yield and purity. The process typically starts with the condensation of 2-aminothiophene with an appropriate electrophile to form the benzothiazole ring. Subsequent functionalization at the 2-position with an amine group and introduction of the isobutyl substituent are critical steps that determine the final properties of the compound. Advanced synthetic techniques such as catalytic hydrogenation and protective group strategies are often employed to achieve the desired product with minimal side reactions.

The chemical stability of N-(2-methylpropyl)-1,3-benzothiazol-2-amine is another important consideration in its application. The compound needs to be stored under controlled conditions to prevent degradation, which could affect its biological activity. Researchers have investigated various storage conditions and stabilizers that can maintain the integrity of the molecule over time. These studies not only contribute to the practical handling of the compound but also provide insights into its potential long-term use in pharmaceutical formulations.

One of the most compelling aspects of N-(2-methylpropyl)-1,3-benzothiazol-2-amine is its potential as a lead compound for drug development. Its unique structural features make it a versatile scaffold that can be modified to target different disease mechanisms. For example, researchers have explored its use in developing treatments for neurological disorders by investigating its interaction with neurotransmitter receptors. Additionally, its antimicrobial properties have prompted studies into its efficacy against resistant bacterial strains.

The role of computational chemistry in understanding the behavior of N-(2-methylpropyl)-1,3-benzothiazol-2-amine cannot be overstated. Molecular modeling techniques have been instrumental in predicting how this compound might interact with biological targets at the atomic level. These predictions help guide experimental design and can significantly reduce the time and cost associated with drug discovery. By integrating experimental data with computational insights, researchers can gain a more comprehensive understanding of the compound's mechanism of action.

Ethical considerations are also paramount when studying compounds like N-(2-methylpropyl)-1,3-benzothiazol-2-amine. Ensuring that research is conducted responsibly and with appropriate regulatory oversight is crucial for advancing scientific knowledge while minimizing potential risks. Collaborative efforts between academic institutions, pharmaceutical companies, and regulatory bodies help ensure that these standards are met and that progress is made in an ethical manner.

The future directions for research on N-(2-methylpropyl)-1,3-benzothiazol-2-amine are promising and multifaceted. Continued investigation into its biological activities will likely uncover new therapeutic applications beyond those currently envisioned. Additionally, exploring novel synthetic routes could lead to more efficient production methods and lower costs for derivative compounds. As our understanding of disease mechanisms evolves, so too will our ability to design molecules like N-(2-methylpropyl)-1,3-benzothiazol-2-amine that can effectively address unmet medical needs.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)